 PHILADELPHIA, Jan. 04, 2021 GLOBE NEWSWIRE -- Passage Bio, Inc. Nasdaq: PASG, a genetic medicines company focused on developing transformative therapies for rare, monogenic central nervous system disorders, today announced that Bruce Goldsmith, Ph.D., president and chief executive officer will present a company overview at the J.P Morgan 39th Annual Healthcare Conference being held virtually on Monday, January 11, 2021 at 7:30am ET. 